Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study
NCT ID: NCT04964154
Last Updated: 2021-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
4000 participants
INTERVENTIONAL
2021-02-17
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake
NCT04957082
SHE Tribe: An Intervention to Improve Health Behavior Among Women in Underserved Communities
NCT03463213
Diabetes Virtual Trek: Obesity and Diabetes Prevention Through Science Enrichment
NCT00542113
Family-Centered Diabetes Project - Sharing Wisdom
NCT00438126
Protecting Native Families From COVID-19
NCT04765475
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BRAVE Non-Intervention
Survey participants in the BRAVE non-intervention arm will not have received information (e.g., informational pamplets, flyers, townhalls) about COVID-19 testing and vaccination from the BRAVE project.
No interventions assigned to this group
BRAVE Intervention
Survey participants in the BRAVE intervention arm will have received information (e.g., informational pamplets, flyers, townhalls) about COVID-19 testing and vaccination from the BRAVE project.
Protect Your Elders Campaign
This is a behavioral intervention where participants will receive cultural appropriate educational information about COVID-19 testing and vaccination.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protect Your Elders Campaign
This is a behavioral intervention where participants will receive cultural appropriate educational information about COVID-19 testing and vaccination.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lumbee Tribe of North Carolina
UNKNOWN
University of North Carolina at Pembroke
UNKNOWN
North Carolina Central University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deepak Kumar
Director of Julius L. Chambers Biomedical/Biotechnology Research Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deepak Kumar, PhD
Role: PRINCIPAL_INVESTIGATOR
North Carolina Central University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lumbee Tribe Tribal Housing Complex
Pembroke, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1201571
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.